In our current results, the global visual scores in [18F]Florzolotau tau-PET images from AD-associated regions showed significant positive correlations with the CDR-SOB scores (p < 0.0001), demonstrating that the increasing tau burden identified by the visual reading score closely correlated with decreasing cognition and increasing disease severity. The gene discussed is MAPT; the disease is Alzheimer disease.